Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NATALIZUMAB vs NEFOPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NATALIZUMAB vs NEFOPAM: Safety Overview

Metric NATALIZUMAB NEFOPAM
Total FAERS Reports 64,315 2,857
Deaths Reported 3,140 360
Death Rate 4.9% 12.6%
Hospitalizations 17,879 1,685
Average Patient Age 45.6 yrs 55.0 yrs
% Female Patients 78.5% 54.4%
Manufacturer Sandoz Inc N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A